CAPR - יחס חוב להיוון בספרים capricor.com

Capricor Therapeutics (CAPR) relies on a complex low-temperature biomaterial transport system, which protects raw materials and sustains high profits. This chart of stock quotes confirms the asset's dynamics, with a metric of 0.36. The company is building a scientific ecosystem around exosomes and cellular treatment for cardiovascular pathologies while adhering to strict laboratory waste disposal standards.

When screening business quality, an investor assesses a company's stability by comparing total liabilities to its equity. This calculated ratio determines the proportion of borrowed funds within the balance sheet structure, which for Capricor Therapeutics (CAPR) confirms management's financial discipline in implementing Duchenne therapy, reflecting this indicator of capital structure risk on the balance sheet.